Genetic obestiy: estrogenic influences on the body weight and food intake of lean and obese adult Zucker (fa/fa) rats

The effects of chronic estrogen withdrawal and subsequent hormone replacement on the feeding and body weight of adult lean and genetically obese Zucker rats were investigated. Following confirmation of a delay in the vaginal canalization of the fatty rat, subgroups of each genotype received either ovariectomy or sham surgery (Experiment 1). One hundred days later all subjects were injected subcutaneously (SC) with 1.0 microgram of estradiol benzoate (EB) daily for 16 treatment days (Experiment 2A). A second series of daily 2.0 microgram EB injections was administered intraperitoneally (IP) for 1 week (Experiment 2B). The first experiment revealed that ovariectomy produced overeating and similar weight gains in both genotypes. In the second experiment, SC hormone treatment completely reversed ovarian obesity in lean animals but failed to alter the food intake or weight gain of fatty rats. IP administration of EB depressed the feeding of fatty and lean animals to a comparable degree but a reduction in weight gain was observed only in the lean rats. These findings are discussed in light of current theories of estrogenic modulation of energy balance.     

Small-cell carcinoma of the ovary in peritoneal fluid

Two cases of small-cell carcinoma of the ovary in the ascitic fluid and peritoneal/pelvic washings of a 30- and 28-yr-old woman, respectively, are presented and discussed. Smear preparations from the ascitic fluid showed loose clusters and single malignant cells with scant cytoplasm and nuclei with smooth to irregular nuclear membranes, granular chromatin, and small nucleoli. In the second case peritoneal/pelvic washing specimens contained clusters and single malignant cells with a moderate amount of cytoplasm and nuclei with smooth nuclear membranes, granular, clumped chromatin, and prominent nucleoli. Histology confirmed the diagnosis of small-cell carcinoma of the ovary. These are the first reported cases of this rare ovarian neoplasm present on fluid cytology. Its differentiation from other small-cell neoplasms on peritoneal fluid cytology from young women is discussed. Diagn Cytopathol 1994; 11:266–270. © 1994 Wiley-Liss, Inc.     

卵巢女性化性索间质性肿瘤39例临床病理分析

重新复查我院1960～1980年收治原诊为卵巢女性化性索间质性肿瘤39例的病理切片,可疑者再切片作特殊染色,复查后纠正了11例误诊病例,对确诊的28例的临床表现、病理特征、随访结果及预后等进行了分析。讨论了误诊病例的病理后,建议此类肿瘤中的粒层细胞瘤命名为“恶性粒层细胞瘤”,其恶性度与细胞分级密切相关,预后与卵巢外扩散及治疗是否彻底相关。     

CT在卵巢肿瘤中的应用价值

目的 :评价卵巢肿瘤的CT诊断价值。方法 :搜集经手术和病理证实的 2 0例卵巢肿瘤 ,对其CT表现作回顾性分析。结果 :2 0例卵巢肿瘤中 ,单纯性卵巢囊肿 2例 ,卵巢成熟性畸胎瘤 4例 ,卵巢甲状腺肿 1例 ,卵巢囊腺瘤 3例 ,卵巢无性细胞瘤1例 ,卵巢颗粒细胞瘤 1例 ,卵巢癌 8例。结论 :CT对卵巢肿瘤的定位及定性诊断有重要的价值 ,但对卵巢良、恶性肿瘤的鉴别须结合病史和年龄。     

人卵巢癌SCID小鼠移植瘤模型、细胞系建立及其生物学特性研究

目的建立人卵巢癌SCID小鼠移植瘤模型和相应体外细胞系.方法将病理证实的人卵巢浆液性乳头状腺癌手术切除标本移植于SCID小鼠皮下,成瘤后行鼠间传代,取移植瘤细胞体外分离培养、传代和建系,并应用细胞、分子生物学手段对移植瘤和建系细胞进行一系列生物学特性检测.结果历时14个月传至5代,皮下移植瘤存活率为90%,持续6个月,体外建系(OVA-319)细胞生长稳定.镜下观察组织形态学和超微结构符合原肿瘤组织基本特征;染色体分布在12～46条之间,多为异倍体,显示人类肿瘤异常染色体;流式细胞术和RT-PCR技术分析原代、体内移植瘤和OVA-319细胞结果一致,表现为瘤细胞生长活跃、细胞周期分布相仿,MAGE-2基因在mRNA水平异常表达.结论人卵巢癌SCID小鼠移植瘤模型和OVA-319细胞系为人类肿瘤的研究提供了良好的实验材料.     

诊断卵巢恶性肿瘤最佳标志群的研究

目的研究22种肿瘤标志(TM)对诊断卵巢恶性肿瘤(OMN)的价值,选择最佳诊断标志群.方法用高压液相色谱法、自动生化仪检测法、酶联免疫法检测.结果单项TM的敏感性≥60%者分别为腐胺(100%)、精脒(84%)、CA125(80%)、唾液酸(SA)(70.4%)、铁蛋白(61.2%)、肿瘤特异生长因子(TS-GF)(60.9%)和CA153(60%).有效率≥80%者分别是TSGF(88.6%)、精胺(86.6%)、精脒(83.8%)、CA153(81.2%)、SA(81.1%)、腐胺(81.0%)和CA125(80%).最佳标志群为CA125、TSGF和SA.结论CA125是诊断OMN最敏感的TM,其次是SA、铁蛋白和TSGF.TM联合测定能提高诊断的有效性,其中以CA125、TSGF和SA联合测定效果较好.     

肾透明细胞癌和卵巢癌与HLAI类抗原关联性研究

目的 分析HLAI类抗原与肾透明细胞癌和卵巢癌的关联性。为确定与这些肿瘤的易感性和抵抗性有关的基因。并为寻找肿瘤特异性的抗原肽,开展肿瘤免疫诊断和治疗奠定基础。方法 实验采用微量淋巴细胞毒试验。分析82例肾透明细胞癌和21例卵巢癌患者外周血HLA-A抗原和-B抗原的抗原频率。结果 与肾透明细胞癌和卵巢癌关联的HLAI类完全不同,其中与肾透明细胞癌关联的位点大大多于卵巢癌的位点,有A9、A11、A28、BG15、B22、B27和B40;而与卵巢癌关联的HLAI类抗原位点只有A10、A36和B12,且卵巢癌关联A10抗原保持显著关联。结论 HLAI类抗原关联性研究显示,HLA-A10可能为卵巢癌提供抵抗性。     

Clinical and cytogenetic aspects of X-chromosome deletions

Karyotype/phenotype correlations in six non-mosaic patients with dysgenetic ovaries and partial deletions of the X-chromosome (three patients with short arm, and three with long arm deletions) are presented and the pertinent literature is analysed. It would appear that functioning ovarian tissue is present more often in patients with a short arm deletion than in those with a deleted long arm. This may represent a difference in the strength of two sets of controlling factors, but it can also be related to break point position. This in turn may be misinterpreted due to the difficulty in distinguishing between terminal and interstitial deletions in the long arm. Stature may be a heterochromatic effect, but if specific genetic factors influencing stature exist, then they would appear to be situated mostly on the short arm of the X-chromosome, although some 'statural determinants' occur also on the long arm and could be located rather close to the centromere. Deletions of the short arm of the X-chromosome were almost always associated with some features of the Turner phenotype, and could possibly be related to a gene dosage effect.     

逆转录病毒介导的人卵巢癌 p53基因治疗体外及小鼠体内实验研究

目的 :评价人卵巢癌的 p5 3基因治疗效果。 方法 :用携带人野生型 p5 3的逆转录病毒转导 p5 3蛋白表达缺如的人卵巢癌细胞系SK OV 3,通过体外及小鼠体内实验研究转基因的表达及对肿瘤的抑制作用。结果 :逆转录病毒介导的 p5 3基因能够在体外及小鼠体内人卵巢癌细胞SK OV 3中表达 ,并对人卵巢癌生长有抑制作用。体外抑制率为 5 7%～ 88% ;对体内肿瘤抑制率为 40 %。结论 :逆转录病毒介导的外源野生型p5 3能够抑制人卵巢癌生长 ,增加病毒滴度将进一步提高体内治疗效果